Connection

Donald Castell to Gastrointestinal Agents

Back to Details
This is a "connection" page, showing publications Donald Castell has written about Gastrointestinal Agents.
Donald Castell
Connection Strength
2.524
Gastrointestinal Agents
  1. Impact of Peppermint Therapy on Dysphagia and Non-cardiac Chest Pain: A Pilot Study. Dig Dis Sci. 2019 08; 64(8):2214-2218.
    View in: PubMed
    Score: 0.619
  2. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2010 Jun; 105(6):1266-75.
    View in: PubMed
    Score: 0.329
  3. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):155-62.
    View in: PubMed
    Score: 0.258
  4. Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water. Am J Gastroenterol. 2003 Mar; 98(3):517-8.
    View in: PubMed
    Score: 0.205
  5. Medical therapy for gastroesophageal reflux disease. Mayo Clin Proc. 2001 Jan; 76(1):102-6.
    View in: PubMed
    Score: 0.176
  6. Medical therapy of supraesophageal gastroesophageal reflux disease. Am J Med. 2000 Mar 06; 108 Suppl 4a:170S-177S.
    View in: PubMed
    Score: 0.167
  7. Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal. The CIS-USA-89 Study Group. Aliment Pharmacol Ther. 1999 Jun; 13(6):787-94.
    View in: PubMed
    Score: 0.158
  8. Effects of octreotide on esophageal visceral perception and cerebral evoked potentials induced by balloon distension. Am J Gastroenterol. 1999 Jan; 94(1):65-70.
    View in: PubMed
    Score: 0.154
  9. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Am J Gastroenterol. 1998 Apr; 93(4):547-52.
    View in: PubMed
    Score: 0.146
  10. Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther. 2011 Apr; 33 Suppl 1:1-71.
    View in: PubMed
    Score: 0.090
  11. Pirenzepine and propantheline effects on esophageal pressure responses to bethanechol. Am J Gastroenterol. 1986 May; 81(5):334-8.
    View in: PubMed
    Score: 0.064
  12. Management of gastroesophageal reflux disease. Am J Med Sci. 2003 Nov; 326(5):309-18.
    View in: PubMed
    Score: 0.054
  13. Gastroesophageal reflux disease: natural history and long-term medical and surgical outcomes. Clin Cornerstone. 2003; 5(4):51-7; discussion 58-60.
    View in: PubMed
    Score: 0.051
  14. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000 Nov; 14(11):1503-9.
    View in: PubMed
    Score: 0.044
  15. Current approaches in the medical treatment of oesophageal reflux. Drugs. 1981 Apr; 21(4):283-91.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.